CARNOVALE, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 574
EU - Europa 367
AS - Asia 319
SA - Sud America 11
AF - Africa 10
Totale 1.281
Nazione #
US - Stati Uniti d'America 570
IT - Italia 192
SG - Singapore 140
HK - Hong Kong 76
CN - Cina 61
NL - Olanda 36
DE - Germania 30
VN - Vietnam 28
RU - Federazione Russa 24
FI - Finlandia 19
HU - Ungheria 16
SE - Svezia 15
BR - Brasile 10
CI - Costa d'Avorio 10
IE - Irlanda 9
AT - Austria 5
UA - Ucraina 5
BE - Belgio 3
BG - Bulgaria 3
CA - Canada 3
FR - Francia 3
GB - Regno Unito 3
IL - Israele 3
IN - India 3
LT - Lituania 3
IR - Iran 2
PK - Pakistan 2
CY - Cipro 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
PE - Perù 1
PL - Polonia 1
TR - Turchia 1
Totale 1.281
Città #
Chandler 109
Singapore 93
Hong Kong 76
Ashburn 68
Napoli 55
Santa Clara 53
Naples 42
Amsterdam 34
Dong Ket 28
Millbury 19
Lawrence 17
Beijing 15
Des Moines 15
Helsinki 13
Boston 12
Falkenstein 9
Budapest 8
Washington 8
Fairfield 7
Munich 7
Princeton 7
Frankfurt am Main 6
Jacksonville 6
Nanjing 6
Wilmington 6
Mugnano Di Napoli 5
Szeged 5
Los Angeles 4
Rome 4
Shanghai 4
Brussels 3
Dublin 3
Guangzhou 3
Gödöllő 3
Limatola 3
Pomarico 3
Pune 3
Seattle 3
Sofia 3
Woodbridge 3
Acerra 2
Changsha 2
Ferrara 2
Formia 2
Fuzhou 2
Gargazon 2
Jiaxing 2
Lappeenranta 2
London 2
Milan 2
Nanchang 2
Nuremberg 2
Ottawa 2
Palermo 2
Rio de Janeiro 2
San Severo 2
The Dalles 2
Tianjin 2
Vienna 2
Afragola 1
Americana 1
Anshan 1
Arpino 1
Avellino 1
Beersheba 1
Boardman 1
Casavatore 1
Casoria 1
Cava De' Tirreni 1
Chengdu 1
Chongqing 1
Cormeilles-en-Parisis 1
Corrente 1
Dallas 1
Fiumicino 1
Frattamaggiore 1
Fremont 1
Grenoble 1
Guimarães 1
Harbin 1
Jamaica Plain 1
Karachi 1
Kunming 1
Lamezia Terme 1
Lima 1
Lu'an 1
Marcianise 1
Mexico City 1
Moscow 1
Nicosia 1
Pioltello 1
Potenza 1
Pozzuoli 1
Redwood City 1
San Francisco 1
Santa Maria La Carita 1
Shenyang 1
Sindelfingen 1
Solopaca 1
Suzhou 1
Totale 850
Nome #
Clinical expression of patients with the D1152H CFTR mutation 87
Cystic Fibrosis: The Sense of Smell 65
Cystic Fibrosis: the sense of smell. 62
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 62
Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study 61
Inhalation therapy in cystic fibrosis 55
Olfactory performance in Cystic Fibrosis patients 55
Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules 55
Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis 54
The role of nasal washes in CF patients affected by chronic rhinosinusitis 54
Salivary cytokines and airways disease severity in patients with cystic fibrosis 53
Clinical expression of cystic fibrosis in a large cohort of Italian siblings 50
The role of nasal washes in patients with Cystic Fibrosis affected by chronic rhinosinusitis 45
Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers 45
A new method to improve the clinical evaluation of Cystic Fibrosis patients by mucus viscoelastic properties 44
Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic Fibrosis 43
Influence of pancreatic status on circulating plasma sterols in patients with cystic fibrosis 41
Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis 41
Lipidomic alterations in human saliva from cystic fibrosis patients 40
Supervised physical exercise improves clinical, anthropometric and biochemical parameters in adult cystic fibrosis patients: A 2-year evaluation 40
The impact of cystic fibrosis on the working life of patients: A systematic review 36
Physical activity regulates tnfα and il-6 expression to counteract inflammation in cystic fibrosis patients 34
Employment status and work ability in adults with cystic fibrosis 32
Incidental late diagnosis of cystic fibrosis following AH1N1 influenza virus pneumonia: A case report 29
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations 27
Cystic Fibrosis in Adults: A Paradigm of Frailty Syndrome? An Observational Study 20
One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes 19
Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study 18
Beneficial economic effect of a virtual model of care for cystic fibrosis 18
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype 17
Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment 16
Clinical outcomes of digital health in adults with cystic fibrosis 16
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype 14
Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences 12
Metabolomic profiling of saliva from cystic fibrosis patients 10
Totale 1.370
Categoria #
all - tutte 6.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 0 0 0 2 24 13 2
2020/2021105 11 1 25 10 2 3 4 7 8 4 2 28
2021/2022185 8 0 2 1 2 18 7 3 8 29 57 50
2022/2023274 25 21 15 13 34 31 5 22 53 38 12 5
2023/2024226 9 22 15 18 15 46 18 19 10 12 27 15
2024/2025455 50 37 0 29 38 101 99 88 13 0 0 0
Totale 1.370